Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Hyaline Capital launches macro-driven long/short equity hedge fund

Thursday, September 27, 2012

From Komfie Manalo, Opalesque:

Hyaline Capital Management recently launched a top-down, macro-driven long/short equity hedge fund, domiciled in Delaware. The new investment firm is located on Fifth Avenue in New York.

In an email sent to Opalesque, Hyaline’s co-founder Justin Meadlin said the fund’s focus is on macro and sector investments via ETFs as well as single stock selection across industries, with a particular focus on the consumer, retail, industrial and financial sectors.

"We believe our investment process is … well suited for today’s volatile markets as it incorporates macro, fundamental and technical analysis with a high priority on liquidity, transparency and preservation of capital," he said.

The fund will also utilize a three-pronged investment strategy that integrates macro, fundamental and technical analysis, in a process that is expected to be scalable and repeatable.

To align the fund with investor interest, Meadline, COO and head of business development, said that he and co-fonder Tony D’Andraia, CEO and CIO, would maintain a significant portion of their net worth in the fund.

Before launching Hyaline, Meadlin was a Managing Director at FBR Capital Markets for five years and Banc of America and Credit Suisse before that. D’Andraia spent the past two years managing $100m on the Morgan Stanley Prop desk and worked at Avesta Capital and Moore Capital before that.

The ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for